Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Atopic Dermatitis (AD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT07105488
What this trial is testing

A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Bluefin Biomedicine, Inc. 225
Post-approval studies (Phase 4)WithdrawnNCT07187089
What this trial is testing

Study of Growth and Bone Mineral Density in Children With Atopic Dermatitis (AD) Treated With Dupilumab

Who this might be right for
Severe Atopic Dermatitis (AD)
Regeneron Pharmaceuticals
Testing effectiveness (Phase 2)Looking for participantsNCT07445919
What this trial is testing

A Clinical Study to Evaluate SM17 for Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
SinoMab BioScience Ltd 200
Large-scale testing (Phase 3)Ended earlyNCT05882877
What this trial is testing

Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Amgen 2,621
Large-scale testing (Phase 3)Study completedNCT05704738
What this trial is testing

Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Amgen 532
Large-scale testing (Phase 3)Ended earlyNCT05732454
What this trial is testing

Learn About the Study Medicine Etrasimod in Adults With Moderate to Severe Atopic Dermatitis (AD) Who Have Already Tried Treatments Taken by Mouth or by Injection

Who this might be right for
Atopic DermatitisAtopic Dermatitis, UnspecifiedEczema+1 more
Pfizer 58
Testing effectiveness (Phase 2)Ended earlyNCT06881251
What this trial is testing

JNJ-95475939 in the Treatment of Participants With Moderate to Severe Atopic Dermatitis (AD)

Who this might be right for
Dermatitis, Atopic
Janssen Research & Development, LLC 256
Early research (Phase 1)Looking for participantsNCT07235384
What this trial is testing

A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Zai Lab (Shanghai) Co., Ltd. 84
Testing effectiveness (Phase 2)Study completedNCT05470114
What this trial is testing

A Multi-omics Disease Signature Trial in Adult Patients With Moderate to Severe AD

Who this might be right for
Atopic Dermatitis
LEO Pharma 13
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07810777
What this trial is testing

PRA-216 Atopic Dermatitis Safety and Efficacy Study

Who this might be right for
Atopic Dermatitis (AD)
Prana Therapies Inc 39
Large-scale testing (Phase 3)Study completedNCT05601882
What this trial is testing

Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
AbbVie 920
Not applicableStudy completedNCT04541810
What this trial is testing

Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ankylosing Spondylitis or Psoriatic Arthritis

Who this might be right for
Rheumatoid Arthritis (RA)Atopic Dermatitis (AD)Ankylosing Spondylitis (AS)+1 more
AbbVie 2,369
Testing effectiveness (Phase 2)Study completedNCT03151148
What this trial is testing

Targeted Microbiome Transplant in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
National Institute of Allergy and Infectious Diseases (NIAID) 54
Early research (Phase 1)Study completedNCT06345404
What this trial is testing

Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Participants With Moderate to Severe AD

Who this might be right for
Atopic Dermatitis
Corvus Pharmaceuticals, Inc. 82
Testing effectiveness (Phase 2)Active Not RecruitingNCT06176040
What this trial is testing

TAVO101 in Atopic Dermatitis Patients

Who this might be right for
Atopic Dermatitis
Tavotek Biotherapeutics 20
Large-scale testing (Phase 3)Looking for participantsNCT07355075
What this trial is testing

A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)

Who this might be right for
Eczema Atopic DermatitisEczemaAtopic Dermatitis
Turn Therapeutics 190
Not applicableAvailableNCT05466578
What this trial is testing

Pre-approval Single-patient Expanded Access for Abrocitinib (PF-04965842)

Who this might be right for
Severe Uncontrolled Atopic Dermatitis
Pfizer
Testing effectiveness (Phase 2)Study completedNCT02210780
What this trial is testing

Study of Dupilumab and Immune Responses in Adults With Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Regeneron Pharmaceuticals 194
Not applicableActive Not RecruitingNCT07582237
What this trial is testing

Long-Term Follow-up Study of FURESTEM-AD in Patients With Atopic Dermatitis(K0106)

Who this might be right for
Dermatitis, Atopic
Kang Stem Biotech Co., Ltd. 262
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07175233
What this trial is testing

Evaluate the Efficacy, Safety of SIM0278 in Subjects With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Jiangsu Simcere Pharmaceutical Co., Ltd. 184
Next Page